Relationship Between Kinesiophobia, Physical Activity and Disability Level and Pain Management in Patients With CLBP

November 8, 2023 updated by: Ayse Unal, Alanya Alaaddin Keykubat University

The Relationship Between Kinesiophobia, Physical Activity and Disability Level and Pain Management in Patients With Chronic Low Back Pain in Genders

The aim of this study was to examine the relationship between pain management, kinesiophobia, physical activity and disability level in patients with chronic low back pain (CLBP) in different genders. Eighty-two patients with CLBP (42 females, 42 males) between the ages of 20-60 participated in the study. Pain management strategies were determined by Pain Coping Questionnaire (PCQ). Tampa Scale for Kinesiophobia for perception of kinesiophobia, Oswestry Disability Index for disability due to pain and International Physical Activity Questionnaire-Short Form (IPAQ-SF) for the physical activity level were used.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

82

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Denizli, Turkey, 20160
        • Pamukkale University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

One hundred twenty-six subjects were invited to participate in the study. The study was completed with the participation of 84 subjects, 42 women and 42 men.

Description

Inclusion Criteria:

  • Individuals who are between 20 and 60 years old,
  • Experienced low back pain lasting longer than 3 months, and had no problems with reading, writing, and comprehension were included in the study.

Exclusion Criteria:

  • Individuals who underwent surgery for low back pain,
  • Had any diagnosed spinal problem,
  • Who were pregnant,
  • And who had communication problems were not included in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Female
Forty one females with CLBP between the ages of 20-60 participated in the study. Pain management strategies were determined by Pain Coping Questionnaire (PCQ). Tampa Scale for Kinesiophobia for perception of kinesiophobia, Oswestry Disability Index for disability due to pain and International Physical Activity Questionnaire-Short Form (IPAQ-SF) for the physical activity level were used.
Other: Pain management
Investigation of relationship between kinesiophobia, physical activity and disability level and pain management in patients with CLBP
Male
Forty one males with CLBP between the ages of 20-60 participated in the study. Pain management strategies were determined by Pain Coping Questionnaire (PCQ). Tampa Scale for Kinesiophobia for perception of kinesiophobia, Oswestry Disability Index for disability due to pain and International Physical Activity Questionnaire-Short Form (IPAQ-SF) for the physical activity level were used.
Other: Pain management
Investigation of relationship between kinesiophobia, physical activity and disability level and pain management in patients with CLBP

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Coping Questionnaire (PCQ)
Time Frame: From 25 December 2019 to 10 November 2021
The scale assesses how chronic pain patients cope with organic or psychogenic pain. The scale consists of four subdimensions that are self-coping, helplessness, conscious cognitive interventions, and seeking medical help, and 29 items. The self-report scale consists of a 4-point Likert scale (0: never, 3: often).
From 25 December 2019 to 10 November 2021

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analogue Scale (VAS)
Time Frame: From 25 December 2019 to 10 November 2021
Subjects were asked to mark the severity of pain on a 10-cm line. The lowest point indicated the least severity of pain, and the highest point indicated the maximum pain value.
From 25 December 2019 to 10 November 2021
Oswestry Disability Index (ODI)
Time Frame: From 25 December 2019 to 10 November 2021
It consists of 10 items measuring the severity of pain, personal care, lifting, walking, sitting, standing, social life, sleeping, traveling, and degree of pain. Each item is scored between 0-5. The higher the total score, the higher the degree of disability. The maximum score is 50 points.
From 25 December 2019 to 10 November 2021
Tampa Scale of Kinesiophobia (TSK)
Time Frame: From 25 December 2019 to 10 November 2021
The scale is scored between 17 and 68 using a 4-point Likert type scale scoring system. A high score on the scale indicates a high level of kinesiophobia.
From 25 December 2019 to 10 November 2021
International Physical Activity Questionnaire-Short Form (IPAQ -SF)
Time Frame: From 25 December 2019 to 10 November 2021
The questionnaire provides information on time spent walking, moderate to vigorous activity, and vigorous activity. Time spent sitting is included as a separate question. The total score calculation includes the sum of time (minutes) and frequency (days) of walking, moderate activity, and vigorous activity.
From 25 December 2019 to 10 November 2021

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Alanya Alaaddin Keykubat University

Investigators

  • Principal Investigator: Ayşe Ünal, Assoc. Prof, Alanya Alaaddin Keykubat University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 25, 2019

Primary Completion (Actual)

November 20, 2021

Study Completion (Actual)

December 28, 2021

Study Registration Dates

First Submitted

November 3, 2023

First Submitted That Met QC Criteria

November 8, 2023

First Posted (Estimated)

November 9, 2023

Study Record Updates

Last Update Posted (Estimated)

November 9, 2023

Last Update Submitted That Met QC Criteria

November 8, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 60116787-020/92289

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on Pain management

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe